Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 3, Issue 3, 2022

Study on the mechanism of shejianlian compound regulating the transformation of viral hepatitis, inflammation and cancer based on PI3K Akt / WT1

Download as PDF

DOI: 10.23977/medsc.2022.030308 | Downloads: 8 | Views: 812

Author(s)

Zhuoran Ji 1, Man Wang 2, Mingxia Hao 2, Xiaoni Kou 2

Affiliation(s)

1 Shaanxi University of traditional Chinese medicine, Shaanxi Xianyang 712000, China
2 Affiliated Hospital of Shaanxi University of traditional Chinese Medicine, Shaanxi Xianyang 712000, China

Corresponding Author

Xiaoni Kou

ABSTRACT

Chronic hepatitis B is a systemic infectious disease caused by hepatitis B virus infection. Hepatitis B patients with hepatitis B in the world develop to cirrhosis or even liver cancer. In the process of inflammatory transformation, liver fibrosis is reversible, but the time of reversal is too slow. At present, there is no approved drug for the treatment of liver fibrosis, so the advantage of Chinese medicine in the prevention of liver fibrosis is particularly prominent. 20%-30% Shejianlian compound is composed of Hedyotis diffusa, Shijianchuan and Scutellaria barbata. Based on PI3K Akt / WT1, it can effectively prevent the transformation of viral hepatitis to liver cirrhosis and liver cancer. This paper discusses the mechanism of shejianlian compound regulating inflammatory and cancer transformation through PI3K Akt / WT1.

KEYWORDS

Shejianlian compound, Hepatitis, liver cancer, Inflammatory transformation, mechanism

CITE THIS PAPER

Zhuoran Ji, Man Wang, Mingxia Hao, Xiaoni Kou, Study on the mechanism of shejianlian compound regulating the transformation of viral hepatitis, inflammation and cancer based on PI3K Akt / WT1. MEDS Clinical Medicine (2022) Vol. 3: 43-48. DOI: http://dx.doi.org/10.23977/medsc.2022.030308.

REFERENCES

[1] Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014; 384(9959): 2053-2063.
[2] Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020; 7(3): 308-319. 
[3] Liver disease Professional Committee of Chinese Association of Integrated Traditional and Western Medicine. Chinese Journal of Hepatology, 2019, 27(7): 494-504. (In Chinese) 
[4] Yuan X, Wang B, Yang L, Zhang Y. The role of ROS-induced autophagy in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2018; 42(4): 306-312. 
[5] Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells. 2020; 9(4): 875. 
[6] Altamirano-Barrera A, Barranco-Fragoso B, Méndez-Sánchez N. Management strategies for liver fibrosis. Ann Hepatol. 2017; 16(1): 48-56.
[7] Wang K Q, XING Y L, YU Z W, et al. Mir-182 activates the PI3K/AKT signaling pathway to promote the proliferation, invasion and migration of hepatocellular carcinoma HepG2 cells [J]. Modern oncology, 2020, 28(11): 1855-1859.
[8] PI3K/Akt signaling pathway and liver fibrosis [J]. J clin hepatobiliary diseases, 2013, 29(5): 3 89-392, 396. (In Chinese with English abstract) 
[9] Wei L, Chen Q, Guo A, Fan J, Wang R, Zhang H. Asiatic acid attenuates CCl4-induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways.Int Immunopharmacol. 2018; 60: 1-8.
[10] Kattan SW, Nafie MS, Elmgeed GA, Alelwani W, Badar M, Tantawy MA. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway. J Steroid Biochem Mol Biol. 2020; 198: 105604.
[11] Gao Jun-cha, WANG Yan, JIANG Hui-qing. Sorafenib inhibits collagen synthesis in human hepatic stellate cells [J]. Chinese journal of pathophysiology, 2012, 28(1): 85-89.
[12] Huang Cheng, Li Jun, Ma Taotao. PI3K/Akt signaling pathway and its role in liver fibrosis [J]. Chin J pharmacol, 2011, 27(8): 1037-1041. 
[13] Hastie ND. Wilms' tumour 1 (WT1) in development, homeostasis and disease. Development. 2017; 144(16): 2862-2872.
[14] Kang HJ, Park JH, Chen W, et al. EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation. Cancer Res. 2014; 74(16): 4526-4535.
[15] Mžik M, Chmelařová M, John S, et al. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma. Clin Chem Lab Med. 2016; 54(12): 1971-1980.
[16] Lv L, Chen G, Zhou J, Li J, Gong J. WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1. J Exp Clin Cancer Res. 2015; 34: 119. 
[17] Kendall TJ, Duff CM, Boulter L, et al. Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1. Nat Commun. 2019; 10(1): 4688. 
[18] Wang Xiao, Fan Huanfang, Li Dehui, et al. Advances in anticancer effects of hedyotis diffusa [J]. China pharmacy, 2019, 30(10): 1428-1431. (In Chinese with English abstract)
[19] Li Zimeng, Zhang Jiayan, Li Fei, et al. Advances in antitumor chemical constituents and pharmacological effects of Hedyotis diffusa [J]. Information of Traditional Chinese Medicine, 201, 38(2): 74-79. 
[20] Zhang R, Xu Y, Ekman N, et al. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J Biol Chem. 2003; 278(51): 51267-51276.
[21] Zhang Youquan, Wang Qingtai, Chen Xuzheng, et al. Effects of Hedyotis diffusa on PI3K/Akt signaling pathway in human hepatocellular carcinoma HepG2 cells in nude mice [J]. Oncology Preclinical, 2015(4): 277-280.
[22] Wang Xin, Ma Chuanjiang, Yang Peimin, et al. Advances in anti-inflammatory and anti-tumor effects of hedyotis diffusa [J]. Chinese journal of modern applied pharmacy, 2020, 37(19): 2420-2426. 
[23] Niu Shu-rui, Shi Yun, Yang Xin, et al. Research progress on antitumor effects of chemical constituents from Scutellaria chinensis [J]. China Pharmacy, 201,32(15):1915-1920. (In Chinese) 
[24] Chen Ming, WANG Jutao, WU Jenny, et al. In vivo experimental study on the induction of autophagy by the PI3K/AKT/mTOR pathway of total flavonoids from Scutellaria barbata [J]. China journal of Chinese materia medica, 2017, 42(7): 1358-1364.
[25] Yang Y. Effects of compound Banzhulian granules on MAPK/ERK-PI3K/Akt signaling pathway in liver fibrosis [D]. Guangxi University of Chinese Medicine,2016.
[26] Liang Wei, WANG Songpo. Study on the medicinal ingredients of Shijianchuan and its anti-tumor effect [J]. Modern Oncology, 2014(10): 2492-2494. 
[27] Shu G, Zhao W, Yue L, Su H, Xiang M. Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth. J Ethnopharmacol. 2015; 168:237-247.
[28] Wang N, Tan HY, Chan YT, Guo W, Li S, Feng Y. Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde. Oncotarget. 2017; 8(62): 105848-105859.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4689
Visits: 204374

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.